FI3947360T3 - Serotoniini 5-ht2b:tä estäviä yhdisteitä - Google Patents
Serotoniini 5-ht2b:tä estäviä yhdisteitä Download PDFInfo
- Publication number
- FI3947360T3 FI3947360T3 FIEP20726982.0T FI20726982T FI3947360T3 FI 3947360 T3 FI3947360 T3 FI 3947360T3 FI 20726982 T FI20726982 T FI 20726982T FI 3947360 T3 FI3947360 T3 FI 3947360T3
- Authority
- FI
- Finland
- Prior art keywords
- methanone
- imidazol
- piperidin
- methyl
- biphenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962825051P | 2019-03-28 | 2019-03-28 | |
| PCT/US2020/024969 WO2020198478A1 (en) | 2019-03-28 | 2020-03-26 | Serotonin 5-ht2b inhibitory compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI3947360T3 true FI3947360T3 (fi) | 2024-10-07 |
Family
ID=70775466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP20726982.0T FI3947360T3 (fi) | 2019-03-28 | 2020-03-26 | Serotoniini 5-ht2b:tä estäviä yhdisteitä |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US12240827B2 (https=) |
| EP (1) | EP3947360B1 (https=) |
| JP (1) | JP7454589B2 (https=) |
| CN (1) | CN113631548B (https=) |
| AU (1) | AU2020245614B2 (https=) |
| BR (1) | BR112021019314A2 (https=) |
| CA (1) | CA3134952C (https=) |
| DK (1) | DK3947360T3 (https=) |
| ES (1) | ES2991167T3 (https=) |
| FI (1) | FI3947360T3 (https=) |
| PL (1) | PL3947360T3 (https=) |
| PT (1) | PT3947360T (https=) |
| WO (1) | WO2020198478A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240027076A (ko) * | 2021-07-26 | 2024-02-29 | 조에티스 서비시즈 엘엘씨 | 세로토닌 5-ht2b 억제 화합물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0515995D0 (en) | 2005-08-03 | 2005-09-07 | Sandoz Ag | Organic compounds |
| WO2007097197A1 (ja) * | 2006-02-20 | 2007-08-30 | Astellas Pharma Inc. | アミド誘導体またはその塩 |
| TWI415845B (zh) | 2006-10-03 | 2013-11-21 | Arena Pharm Inc | 用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物 |
| JP2012512877A (ja) * | 2008-12-18 | 2012-06-07 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | セロトニン５−ｈｔ２ｂ受容体阻害剤 |
| US8697739B2 (en) | 2010-07-29 | 2014-04-15 | Novartis Ag | Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof |
-
2020
- 2020-03-26 PL PL20726982.0T patent/PL3947360T3/pl unknown
- 2020-03-26 US US17/441,340 patent/US12240827B2/en active Active
- 2020-03-26 EP EP20726982.0A patent/EP3947360B1/en active Active
- 2020-03-26 JP JP2021557368A patent/JP7454589B2/ja active Active
- 2020-03-26 PT PT207269820T patent/PT3947360T/pt unknown
- 2020-03-26 ES ES20726982T patent/ES2991167T3/es active Active
- 2020-03-26 FI FIEP20726982.0T patent/FI3947360T3/fi active
- 2020-03-26 WO PCT/US2020/024969 patent/WO2020198478A1/en not_active Ceased
- 2020-03-26 AU AU2020245614A patent/AU2020245614B2/en active Active
- 2020-03-26 CN CN202080024800.0A patent/CN113631548B/zh active Active
- 2020-03-26 DK DK20726982.0T patent/DK3947360T3/da active
- 2020-03-26 BR BR112021019314A patent/BR112021019314A2/pt unknown
- 2020-03-26 CA CA3134952A patent/CA3134952C/en active Active
-
2025
- 2025-01-21 US US19/032,924 patent/US20250179046A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20220162183A1 (en) | 2022-05-26 |
| US12240827B2 (en) | 2025-03-04 |
| PL3947360T3 (pl) | 2024-11-04 |
| CA3134952A1 (en) | 2020-10-01 |
| EP3947360A1 (en) | 2022-02-09 |
| AU2020245614A1 (en) | 2021-10-14 |
| US20250179046A1 (en) | 2025-06-05 |
| JP2022527080A (ja) | 2022-05-30 |
| JP7454589B2 (ja) | 2024-03-22 |
| DK3947360T3 (da) | 2024-08-26 |
| WO2020198478A8 (en) | 2021-09-16 |
| ES2991167T3 (es) | 2024-12-02 |
| CA3134952C (en) | 2023-08-08 |
| BR112021019314A2 (pt) | 2021-12-14 |
| CN113631548A (zh) | 2021-11-09 |
| CN113631548B (zh) | 2023-06-06 |
| EP3947360B1 (en) | 2024-08-07 |
| WO2020198478A1 (en) | 2020-10-01 |
| AU2020245614B2 (en) | 2023-01-19 |
| PT3947360T (pt) | 2024-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2213380T3 (es) | Uso de derivados de aril(o heteroaril)azolilcarbinoles para el tratamiento de los trastornos mediados por un exceso de substancia p. | |
| RU2485131C2 (ru) | Производные пиридина, замещенные гетероциклическим кольцом и фосфоноксиметильной группой и содержащие их противогрибковые средства | |
| CN105919998B (zh) | 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂 | |
| BR112014020345B1 (pt) | Composto antiviral, composição farmacêutica compreendendo dito composto e uso dos mesmos para tratar infecção viral ou doença associada à mesma | |
| CA2409741A1 (en) | Tnf-.alpha. production inhibitors | |
| HRP20170351T1 (hr) | Derivati benzimidazol-prolina | |
| FI4014976T3 (fi) | Aprositentaani käytettäväksi kohonneen verenpaineen ja siihen liittyvien sairauksien hoidossa yhdistelmänä valsartaanin kanssa | |
| JP2016512825A5 (https=) | ||
| RU2011119217A (ru) | Производные фенетиламида и их гетероциклические аналоги | |
| RU2008120850A (ru) | Соединения и композиции в качестве ингибиторов протеинкиназ | |
| BRPI0714315B8 (pt) | arilamidas substituídas com tetrazol, seu uso e composição farmacêutica que as compreende | |
| EA022420B1 (ru) | Гетероциклические ингибиторы глутаминилциклазы (qc, ec 2.3.2.5) | |
| RU2011121665A (ru) | Производные 7-гидроксибензимидазол-4-илметанона и содержащие их ингибиторы рвк | |
| NO20074407L (no) | Oral doseringsform omfattende rosiglitazon | |
| AR048691A1 (es) | Compuestos con estructura de alquino con accion antagonista de mch y medicamentos que contienen estos compuestos | |
| JP2017014224A (ja) | 帯状疱疹関連痛の急性期疼痛の予防又は治療剤 | |
| FI3947360T3 (fi) | Serotoniini 5-ht2b:tä estäviä yhdisteitä | |
| CA2312989A1 (en) | Combination therapy for the treatment of migraine | |
| KR20110051194A (ko) | 섬유증의 치료를 위한 피리미딜아미노벤즈아미드 유도체의 용도 | |
| TW200619195A (en) | Phenylpyrrolidine dopamine D3 receptor antagonists | |
| BRPI0606768A2 (pt) | forma de dosagem oral compreendendo rosiglitazona | |
| HRP20250591T1 (hr) | 5‑[[4‑[2‑[5‑(1‑hidroksietil)piridin‑2‑il]etoksi]fenil]metil]‑1,3‑tiazolidin‑2,4‑dion i njegove soli, namijenjen upotrebi u liječenju mitohondrijskih bolesti | |
| PE20161557A1 (es) | Derivados aminoester | |
| HRP20100641T1 (hr) | Imidazolidinonilaminopirimidinski spojevi za liječenje raka | |
| HRP20230793T1 (hr) | Derivati indola i benzimidazola kao dvojni antagonisti 5-ht2a i 5-ht6 receptora |